Autologous OC-L Vaccine and Ovarian Cancer

NCT02452775 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

3

Enrollment

OTHER

Sponsor class

Conditions

Primary Ovarian Cancer
Fallopian Tube Cancer
Primary Peritoneal Cancer

Interventions

BIOLOGICAL: OC-L
OTHER: Montanide
OTHER: poly-ICLC (Hiltonol),

Sponsor

Abramson Cancer Center at Penn Medicine

Collaborators

[object Object]